Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell wall components and endotoxins are a broad class of molecules, often referred to as Pathogen-Associated Molecular Patterns (PAMPs), that are essential for the structural integrity and survival of bacteria and fungi (StatPearls, 2023). The most clinically significant member is Lipopolysaccharide (LPS), or endotoxin, found in the outer membrane of Gram-negative bacteria, which acts as a potent agonist for Toll-like receptor 4 (TLR4), triggering massive inflammatory responses (NIH, 2022). Other key components include peptidoglycan and teichoic acids in Gram-positive bacteria, and beta-glucans in fungal cell walls, all of which are recognized by the host's innate immune system (PubMed, 2021). These molecules serve as critical targets for various therapeutic interventions, including antibiotics like polymyxins that bind and neutralize LPS, and glycopeptides like vancomycin that target peptidoglycan precursors (PubChem, 2023). Furthermore, therapeutic strategies such as hemoperfusion with polymyxin B-immobilized fibers and the use of alkaline phosphatase aim to remove or detoxify these components to prevent the progression of sepsis and septic shock (Journal of Critical Care, 2014). However, targeting these components carries risks, such as the Jarisch-Herxheimer reaction, where rapid microbial lysis leads to a sudden surge of released toxins and systemic inflammation (StatPearls, 2021). Additionally, the use of drugs like polymyxins is limited by significant nephrotoxicity and neurotoxicity (StatPearls, 2023). Overall, while these components are vital for microbial life, their interaction with the host immune system is a primary driver of infectious disease pathology.
Direct binding and neutralization of endotoxins, disruption of microbial membrane integrity through ionic interactions with lipid A, inhibition of cell wall synthesis by binding to structural precursors, and extracorporeal removal from the bloodstream.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall components and endotoxins (PAMPs).